DrugInfoSys

Naproxen

Drug #504

Naproxen is a nonsteroidal anti-inflammatory drug that also possesses antipyretic and analgesic properties. Chemically Naproxen is identified as (+)-6-methoxy-a-methyl-2-naphthalene acetic acid Naproxen is a propionic acid derivative related to ibuprofen, ketoprofen, etc. Many pharmacodynamic similarities exist among these agents, which are usually better tolerated than aspirin or indomethacin. It also has been shown superior to ergotamine in the treatment of migraine. It was approved by the FDA in 1976. The antiinflammatory effects of it may result from the peripheral inhibition of prostaglandin synthesis secondary to inhibition of the enzyme cyclooxygenase. Prostaglandins sensitize pain receptors, and their inhibition is believed to be responsible for the analgesic effects of it

Primary Characteristics

Naproxen is also known as Naproxen Sodium.

It is of Synthetic origin and belongs to Propionic Acid.

It belongs to Cyclo-oxygenase inhibitor pharmacological group on the basis of mechanism of action. It is also classified under Analgesics and Anti-inflammatory Agents .

Molecular Weight: 230.25 · pKa: 4.39 · Solubility in Water: < 1 in 10000 (>1in30) · Solubility in Alcohol: 1 in 25 · Non-proprietary name: Naproxen.

Molecular structure of Naproxen

Pharmacokinetics

Absorption: Naproxen has an oral bioavailability is 100%, pre-systemic (first-pass) metabolism accounts for 2.5% (±2.5%).

Distribution: Naproxen has a volume of distribution is 0.9 l/kg. plasma protein binding is > 99 %.

Elimination: it is metabolised via extensive by Liver, plasma half-life is 12-17hr, renal excretion is 97.5 - 99 %.

Advertisement

Indications

Contraindications

Naproxen is contraindicated in conditions like Hypersensitivity reactions.

Dosage

Naproxen's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
375 mg375 mgMaintanace,To a total maximum daily dose of 1250mg.
750 mg750 mgFor migraine ,At first symtoms of attach.
375 mg375 mgEvery 12hPOFor Musculoskeletal disorder and Dysmenorrhea .Initially given 500 mg which is followed by 250 mg every 6 or 8 hr
625 mg625 mgEvery 12hPOFor rheumatic disease and chronic pain.It should be taken after food
750 mg750 mgEvery 12hPOFor Acute Gout .Initially given 500 mg which is followed by 250 mg every 8 hr
500 mg500 mgRectal (supp)For Musculoskeletal Disorder and Dysmenorrhea .1 suppository given at Bed time followed by 1 suppository in the morning.
Paediatric Dosage (20kg)
10 mg/kg10 mg/kgEvery 12hOral1 month to 18 years which may be increased to 10-15mg/kg twice daily.
Neonatal Dosage (3kg)
No data.

Drug Interactions

Unknown3 interactions
2 interactions
Major1 interaction
Minor1 interaction
Moderate7 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Naproxen in overdosage may give rise to further complications which include Hepatitis , Aplastic anemia , Hemolytic anemia , Aplastic anemia , Hemolytic anemia , Anaphylactoid reactions , Granulocytopenia , Nephrotic syndrome , Peptic ulceration , Acute renal failure , Nephritis , Hemolytic anemia, Breast cancer , Pseudoporphyria , Aplastic anemia, GI perforation.

Naproxen produces potentially life-threatening effects which include Gastric erosion and ulceration, Aplastic Anemia , Anaphylaxis , Gastric hemorrhage, Aplastic anemia. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Naproxen are Nausea, Vomiting, Seizures, Drowsiness, Drowsiness, Anemia, GI disturbances, Hypertension, Indigestion, Hearing loss.

Naproxen is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Allergic Pneumonitis, Cognitive dysfunctions, Constipation , Decreased Creatinine Clearance, Depression, Dizziness, Dreams abnormality, Drowsiness, Dyspepsia , Flu like syndrome, Glaucoma , Headache, Heart burn, Increased intracranial pressure, Jaundice , Leukocytoclastic vasculitis, Light headedness, Malaise, Nausea, Photodermatitis, Pseudoporphyria, Reversible Keratopathy, Stomatitis, Tinnitus, Vertigo, Visual disorders.

Warnings / Precautions

Naproxen should be used with caution in patients with intrinsic coagulation defects and those on anticoagulant therapy. Naproxen may lead to new hypertension or worsening of existing hypertension. Cautions should be taken in heart failure,ulcer or GI bleeding. It should be used with caution in patients with other condition predisposing to fluid retention. It should be used with extra care in the presence of existing controlled infection. Perform periodic auditory function test during chronic therapy. Discontinue drug if skin reaction occurs.

Interference in Pathology

Naproxen may interfere in the diagnosis of False +ve Urinary Conc. of 17-Ketogenic Steroid & of 5-OH Indoleacetic acid .

Available Brands

Click on a strength to view available brands.

Multi-Ingredient Combinations

Storage Conditions

Naproxen should be stored Tab. Suppositries. Suspension.

Drug Classification

  1. 1.2.1.3Non steroidal anti-inflammatory drugs (NSAIDs)
  2. 2.17.4Anti-inflammtory drugs

Manufacturers